Search clinical trials for: medi4736
Total 370 results
-
Yonsei UniversityActive, not recruitingLarynx | Stage II-IVB Operable HNSCC Oral Cavity | Hypopharynx | OropharynxKorea, Republic of
-
Yonsei UniversityRecruitingPotentially Resectable Stage II/IIIa NSCLCKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; MedImmune LLCCompletedAdvanced Colorectal CancerUnited States
-
AstraZenecaActive, not recruitingAdvanced Solid TumoursUnited States
-
MedImmune LLCCompletedCancer | Solid TumorsUnited States, Spain
-
Baylor College of MedicineCompletedMesotheliomaUnited States
-
AstraZenecaCompletedRecurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHNUnited States, France, Italy, Spain, Belgium, Czechia, Romania, Taiwan, Korea, Republic of, Brazil, Hungary, Japan, Russian Federation, Australia, Germany, Israel, Serbia, Bulgaria, Ukraine, Argentina, Poland, Chile, Croatia, Georgia
-
Memorial Sloan Kettering Cancer CenterAstraZenecaActive, not recruitingNonseminomatous Germ Cell Tumor | Seminoma | Germ Cell Tumor | Dysgerminoma | Pineal Germ Cell Tumor | Germinomatous Germ Cell TumorUnited States
-
Monika Joshi, MDAstraZenecaActive, not recruiting
-
Shadia Jalal, MDAstraZeneca; MedImmune LLC; Big Ten Cancer Research ConsortiumCompleted
-
Italian Network for Tumor Biotherapy FoundationAstraZenecaUnknownPeritoneal Mesothelioma | Pleural MesotheliomaItaly
-
AstraZenecaActive, not recruitingNon Small Cell Lung Carcinoma NSCLCPoland, Taiwan, Thailand, Vietnam, United States, Korea, Republic of, Hungary, Russian Federation, Turkey, China, Australia, Netherlands
-
AstraZenecaActive, not recruitingNon-Small-Cell Lung Carcinoma NSCLCUnited States, Belgium, Spain, Canada, Taiwan, Thailand, Vietnam, France, Germany, Italy, Korea, Republic of, Hungary, Japan, Russian Federation, Netherlands, Australia, Switzerland
-
AstraZenecaActive, not recruitingNon-muscle-invasive Bladder CancerFrance, Spain, Belgium, Canada, Poland, Germany, Japan, Russian Federation, United Kingdom, Austria, Australia, Netherlands
-
Memorial Sloan Kettering Cancer CenterAstraZenecaCompletedAdenocarcinoma of the Bladder | Squamous Cell Carcinoma of the Bladder | Metastatic Bladder Cancer | Non-Transitional Cell Carcinoma of the Urothelial Tract | Small Cell of the BladderUnited States
-
AstraZenecaCompletedMetastatic Pancreatic Ductal AdenocarcinomaUnited States, United Kingdom
-
AstraZenecaActive, not recruitingCarcinoma, Non-Small-Cell LungPoland, Taiwan, India, Mexico, Russian Federation, Turkey, China, Korea, Republic of, Philippines, Hong Kong
-
AstraZenecaActive, not recruitingNon Small Cell Lung Carcinoma NSCLCDenmark, United Kingdom, United States, Poland, Brazil, India, Japan, Mexico, Peru, Russian Federation, Turkey, China, Malaysia, Hong Kong, Korea, Republic of, Chile, Israel, Ukraine, Portugal, Greece, Bulgaria, Philippines, Sweden, A... and more
-
MedImmune LLCTerminatedCancer | Solid Tumors | CTCLUnited States, France, Canada
-
CelgeneCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteCanada, Spain, United Kingdom, United States, France, Austria, Germany, Italy, Netherlands, Belgium, Portugal, Poland
-
AstraZenecaCompletedMetastatic Pancreatic Ductal AdenocarcinomaSpain, Canada, Korea, Republic of, Netherlands, United States, Germany
-
MedImmune LLCCompletedGastric or Gastroesophageal Junction AdenocarcinomaCanada, United States, Taiwan, Korea, Republic of, Japan, Singapore
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited States, Germany, Italy, United Kingdom, Canada, France, Korea, Republic of, Netherlands
-
Vastra Gotaland RegionAstraZenecaRecruitingNSCLC, Stage IFinland, Norway, Sweden
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Italy, Canada, France, Germany, Netherlands, Spain
-
CelgeneTerminatedMultiple MyelomaUnited States, Canada, Spain, Italy, Denmark, United Kingdom, Belgium, Sweden, Germany
-
CelgeneCompletedMultiple MyelomaUnited States, Spain, Austria, Greece, Netherlands, Sweden
-
AstraZenecaCompletedCarcinoma, Non- Small Cell LungUnited States, Canada, France, Italy, Netherlands, Spain, Belgium, Poland, Taiwan, Vietnam, Korea, Republic of, Brazil, Czechia, Hungary, Japan, Peru, Russian Federation, Hong Kong, Israel, Greece, Australia, Singapore, Turkey, India, A...
-
Do-Youn OhAstraZenecaActive, not recruiting
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, Germany, Italy, United Kingdom, Belgium, Canada, Korea, Republic of, Taiwan, France
-
AstraZenecaPRA Health SciencesCompletedRecurrent/Metastatic Squamous Cell Carcinoma of Head & NeckUnited States, Canada, France, Spain, Belgium, Czechia, Korea, Republic of, Hungary, Malaysia, United Kingdom, Taiwan, Australia, Germany, Georgia, Israel
-
AstraZenecaActive, not recruitingMuscle Invasive Bladder CancerUnited States, Belgium, France, Germany, Italy, Spain, United Kingdom, Canada, Poland, Taiwan, Vietnam, Turkey, Korea, Republic of, Brazil, Czechia, Japan, Philippines, Israel, Chile, Australia, Netherlands, Russian Federation
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; MedImmune LLCActive, not recruiting
-
Queen Mary University of LondonAstraZeneca; Vall d'Hebron Institute of OncologyActive, not recruitingRenal Clear Cell Carcinoma | Renal Papillary Cell CarcinomaUnited Kingdom
-
MedImmune LLCActive, not recruitingHepatocellular CarcinomaUnited States, Italy, Spain, Taiwan, Korea, Republic of, China, Hong Kong, Japan, Singapore
-
MedImmune LLCCompletedMelanomaItaly, United States, Canada, France
-
AstraZenecaCompletedPancreatic Ductal Adenocarcinoma | Triple-negative Breast Cancer | Urothelial Bladder CancerUnited States, Belgium, Korea, Republic of, Poland, Netherlands
-
German Breast GroupAstraZeneca; CelgeneCompleted
-
MedImmune LLCCompletedStudy to Evaluate the Safety and Pharmacokinetics of MEDI9090 in Subjects With Advanced Solid TumorsAdvanced Solid TumorsUnited States, Japan
-
Asan Medical CenterSeoul National University Bundang Hospital; Hallym University Medical CenterCompletedMetastatic Gastric CancerKorea, Republic of
-
MedImmune LLCCompletedMyelodysplastic SyndromeUnited States, United Kingdom, France, Germany
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationWithdrawnSolitary Bone PlasmacytomaUnited States
-
Grupo Espanol Multidisciplinario del Cancer DigestivoAstraZeneca; Vall d'Hebron Institute of Oncology (VHIO)Recruiting
-
MedImmune LLCActive, not recruitingAdvanced Solid TumorsUnited States, Spain, Belgium, Italy, Korea, Republic of, Canada, Australia, Hungary, United Kingdom, France, New Zealand
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLC; Cure Brain Cancer Foundation...CompletedGlioblastomaUnited States, Australia
-
Jena University HospitalRecruitingPneumonia, Viral | Hospital-acquired Pneumonia | Herpes Simplex | Ventilator Associated Pneumonia | Community-acquired PneumoniaGermany
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerUnited States, Belgium, France, Italy, Spain, United Kingdom, Canada, Hungary, Poland, Thailand, Germany, Korea, Republic of, Czechia, Japan, Philippines, Taiwan, Singapore, Austria
-
Fundacion CRIS de Investigación para Vencer el...AstraZeneca; Apices Soluciones S.L.Completed
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLCCompletedRenal Cell Carcinoma | Cervical Cancer | Breast Cancer | Colorectal Cancer | Ovarian CancerUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Celgene; The Leukemia and Lymphoma SocietyWithdrawnPrimary Myelofibrosis | Polycythemia Vera, Post-Polycythemic Myelofibrosis PhaseUnited States